Akoya Biosciences IncNASDAQ:AKYA
- LAST PRICE2.1300
- TODAY'S CHANGE (%)-0.0500 (-2.2936%)
- Bid / Lots2.0400/ 4
- Ask / Lots2.2100/ 10
- Open / Previous Close2.2100 / 2.1800
- Day Range
- 52 Week Range
- Volume134,481
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AKYA |
|---|---|---|
| 09:32 ET | 6075 | 2.14 |
| 09:41 ET | 2704 | 2.15 |
| 09:43 ET | 500 | 2.13 |
| 09:45 ET | 3060 | 2.14 |
| 09:50 ET | 200 | 2.15 |
| 09:52 ET | 1817 | 2.15 |
| 09:56 ET | 107 | 2.1515 |
| 09:57 ET | 200 | 2.15 |
| 09:59 ET | 700 | 2.14 |
| 10:03 ET | 579 | 2.135 |
| 10:06 ET | 200 | 2.15 |
| 10:08 ET | 100 | 2.14 |
| 10:10 ET | 100 | 2.1475 |
| 10:12 ET | 1551 | 2.15 |
| 10:14 ET | 317 | 2.16 |
| 10:17 ET | 100 | 2.19 |
| 10:19 ET | 406 | 2.2 |
| 10:21 ET | 2549 | 2.195 |
| 10:24 ET | 4100 | 2.185 |
| 10:26 ET | 300 | 2.19 |
| 10:28 ET | 100 | 2.195 |
| 10:30 ET | 200 | 2.195 |
| 10:33 ET | 539 | 2.194 |
| 10:35 ET | 300 | 2.19 |
| 10:42 ET | 400 | 2.17 |
| 10:44 ET | 200 | 2.165 |
| 10:46 ET | 926 | 2.16 |
| 10:53 ET | 750 | 2.16 |
| 10:55 ET | 300 | 2.155 |
| 10:57 ET | 400 | 2.15 |
| 11:00 ET | 200 | 2.14 |
| 11:02 ET | 100 | 2.14 |
| 11:04 ET | 100 | 2.13 |
| 11:06 ET | 100 | 2.125 |
| 11:08 ET | 130 | 2.13 |
| 11:13 ET | 121 | 2.13 |
| 11:15 ET | 217 | 2.14 |
| 11:22 ET | 100 | 2.145 |
| 11:26 ET | 100 | 2.16 |
| 11:29 ET | 100 | 2.16 |
| 11:33 ET | 600 | 2.14 |
| 11:38 ET | 1801 | 2.13 |
| 11:40 ET | 200 | 2.14 |
| 11:44 ET | 4265 | 2.105 |
| 11:45 ET | 600 | 2.1 |
| 11:47 ET | 1529 | 2.11 |
| 11:58 ET | 500 | 2.115 |
| 12:00 ET | 200 | 2.115 |
| 12:02 ET | 600 | 2.11 |
| 12:03 ET | 100 | 2.11 |
| 12:05 ET | 2400 | 2.11 |
| 12:12 ET | 3900 | 2.11 |
| 12:14 ET | 4084 | 2.12 |
| 12:16 ET | 300 | 2.12 |
| 12:20 ET | 850 | 2.127 |
| 12:21 ET | 100 | 2.11 |
| 12:23 ET | 600 | 2.115 |
| 12:25 ET | 1073 | 2.11 |
| 12:27 ET | 500 | 2.11 |
| 12:30 ET | 3216 | 2.124 |
| 12:32 ET | 3408 | 2.12 |
| 12:34 ET | 500 | 2.12 |
| 12:36 ET | 2186 | 2.12 |
| 12:38 ET | 2000 | 2.12 |
| 12:39 ET | 100 | 2.12 |
| 12:41 ET | 3504 | 2.11 |
| 12:43 ET | 5325 | 2.125 |
| 12:45 ET | 743 | 2.12 |
| 12:48 ET | 13341 | 2.135 |
| 12:50 ET | 300 | 2.135 |
| 12:52 ET | 200 | 2.135 |
| 12:54 ET | 5287 | 2.145 |
| 12:56 ET | 1300 | 2.13 |
| 12:57 ET | 500 | 2.12 |
| 12:59 ET | 6799 | 2.13 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Akoya Biosciences Inc | 105.2M | -1.4x | --- |
Fonar Corp | 107.7M | 10.8x | -15.67% |
Harvard Bioscience Inc | 120.3M | -13.6x | --- |
Xylo Technologies Ltd | 3.3M | -0.2x | --- |
ViewRay Inc | 180.0 | 0.0x | --- |
Vaso Corp | 45.6M | 12.6x | --- |
Company Information
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Contact Information
- Headquarters
- 100 Campus Drive, 6Th FloorMARLBOROUGH, MA, United States 01762
- Phone
- 415-765-6980
- Fax
- ---
Executives
- Independent Chairman of the Board
- Robert Shepler
- President, Chief Executive Officer, Director
- Brian Mckelligon
- Chief Financial Officer
- Johnny Ek
- Chief Operating Officer
- Frederic Pla
- General Counsel
- Jennifer Kamocsay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $105.2M |
|---|---|
Revenue (TTM) | $93.6M |
Shares Outstanding | 49.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.47 |
Book Value | $1.09 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -66.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
